Superagers, statins, the latest cholesterol pill and the truth about heart disease risk | Dr Terry Simpson

Cardiovascular health and metabolic disease management remain central to longevity, with a focus on lowering ApoB levels to stabilize arterial plaque. While lifestyle interventions like the MIND diet and resistance training are foundational for preventing cognitive decline and sarcopenia, pharmacological advancements such as PCSK9 inhibitors offer significant potential for reducing atherosclerotic burden. Emerging research into stem cell-derived islet cells provides a promising functional cure for type 1 diabetes, though immunosuppression remains a hurdle. Misinformation regarding dietary choices, such as the over-interpretation of small studies on polyphenol oxidase or the dismissal of established lipid-lowering guidelines, risks patient health. Rigorous screening, including coronary artery calcium scoring and CT angiograms, provides actionable data for managing cardiovascular risk, emphasizing that early intervention is critical to preventing irreversible plaque progression and long-term complications.